Atlas Trials

Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung Carcinoma

Clinical trial NCT03827070 · UNKNOWN

Trial details

NCT number
NCT03827070
Sponsor
Center Trials & Treatment Europe
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2019-03-05
Primary completion
2023-02-21
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.